1. Home
  2. KALA vs DETX Comparison

KALA vs DETX Comparison

Compare KALA & DETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.53

Market Cap

13.3M

Sector

Health Care

ML Signal

HOLD

Logo Liberty Defense Holdings Ltd. Common Shares

DETX

Liberty Defense Holdings Ltd. Common Shares

N/A

Current Price

$2.17

Market Cap

14.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
KALA
DETX
Founded
2009
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
13.3M
14.8M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
KALA
DETX
Price
$0.53
$2.17
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$31.50
N/A
AVG Volume (30 Days)
364.1K
31.5K
Earning Date
04-15-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
67.39
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$1.91
52 Week High
$19.77
$4.25

Technical Indicators

Market Signals
Indicator
KALA
DETX
Relative Strength Index (RSI) 36.00 31.07
Support Level $0.51 $1.91
Resistance Level $0.72 $4.07
Average True Range (ATR) 0.05 0.39
MACD 0.01 -0.06
Stochastic Oscillator 18.67 12.82

Price Performance

Historical Comparison
KALA
DETX

About KALA KALA BIO Inc.

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About DETX Liberty Defense Holdings Ltd. Common Shares

Liberty Defense Holdings Ltd is engaged in the development and commercialization of security detection technologies such as airports, stadiums, schools, and more. The company's Hexwave product utilizes millimeter wave technology and Advanced 3D imaging to detect concealed threats. In addition to HEXWAVE, the company has licensed High-Definition Advanced Imaging Technology (HD-AIT) for body and shoe scanning. The Company operates through three distinct segments: Corporate, HEXWAVE, and Contract. The company generates the majority of its revenue from the Contract segment. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: